Bulletin
Investor Alert

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210324360/composite

$

313.10

Change

0.00 0.00%

Volume

Volume 22,536

Sep 22, 2021, 4:09 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210324360/composite

Today's close

$ 314.18

$ 313.10

Change

-1.08 -0.34%

Day low

Day high

$309.33

$318.03

Open
Open: 314.00

52 week low

52 week high

$138.00

$318.03

Open

Market cap

$17.27B

Average volume

352,590

P/E ratio

175.30

Rev. per Employee

$324,699

EPS

1.79

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. Repligen stock price target raised to $335 from $255 at KeyBanc Capital

    6:15 a.m. Sept. 17, 2021

    - Tomi Kilgore

  2. How a 53-Year-Old Growth Fund Takes the Long View

    9:30 p.m. July 30, 2021

    - Barron's Online

  3. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    8:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  4. Small-Cap ‘Darlings’ Are Perking Up in 2020

    11:47 a.m. Jan. 21, 2020

    - Barron's Online

  5. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    7:28 a.m. July 13, 2019

    - Philip van Doorn

  6. Repligen started at overweight with $42 stock price target at J.P. Morgan

    8:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  7. Repligen stock fair value estimate raised to $47 from $42 at Janney

    11:26 a.m. June 23, 2017

    - Tomi Kilgore

  8. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    7:01 a.m. June 23, 2017

    - Tomi Kilgore

  9. Repligen's stock halted for news pending

    6:58 a.m. June 23, 2017

    - Tomi Kilgore

  10. Repligen's stock was inactive premarket prior to trading halt

    6:59 a.m. June 23, 2017

    - Tomi Kilgore

  11. Investing From the Ground Up

    12:13 a.m. Sept. 15, 2016

    - Barron's Online

  12. Why Danaher’s Purchase of Pall Means More M&A is on the Way

    11:39 a.m. May 13, 2015

    - Barrons Blogs

  13. Bull trend absorbs soft second-quarter start

    10:41 a.m. April 6, 2015

    - Michael Ashbaugh

  14. These are the most profitable Nasdaq biotech companies

    12:36 p.m. March 2, 2015

    - Philip van Doorn

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. bluebird (BLUE) Submits BLA for Gene-Therapy to Treat Thalassemia

    11:40 a.m. Today

    - Zacks.com

  2. 3 Unstoppable Healthcare Stocks to Buy With Just $1,000

    7:27 a.m. Today

    - Motley Fool

  3. Great Performers That Are Still Great Stocks

    3:11 p.m. Sept. 21, 2021

    - Motley Fool

  4. AbbVie (ABBV) Files for Skyrizi in Crohn's Disease With FDA

    12:07 p.m. Sept. 21, 2021

    - Zacks.com

  5. Biogen (BIIB) Reports Mixed Data From Neuropathy Pain Study

    10:58 a.m. Sept. 17, 2021

    - Zacks.com

  6. Repligen acquires Avitide in cash and stock deal of $150M

    7:47 a.m. Sept. 16, 2021

    - Seeking Alpha

  7. The Landslide Portfolio

    8:18 p.m. Sept. 14, 2021

    - Seeking Alpha

  8. BioMarin's (BMRN) Dwarfism Drug Gets Approval in Europe

    11:02 a.m. Aug. 30, 2021

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  1. Chromatography Resin Market Trends and Forecast 2028

    5:14 a.m. July 23, 2021

    - Market Insight Reports

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.